Note: Ingredients listed on restricted chemical lists
EC/CAS
247-063-2/25513-64-8
Name of the chemical
mixture of (35-45 % w/w) 1,6-diamino-2,2,4-trimethylhexane and (55-65 % w/w)1,6-diamino-2,4,4-trimethylhexane
Concentration
10 - 20
EC/CAS
238-878-4/14808-60-7
Name of the chemical
Silica, crystalline
Concentration
3 - 10
General Information
Version
1.0
Revision date
2022-07-06
Product name
METOFIX CB-A2 COMP B
1.2.1 Relevant identified uses
Industrial use,Professional use
Emergency telephone
+44 (0)1924 431679, 0344 892 0111
Icons in SDS
Company Information
company name
Chemfix Products Limited
e-mail address of the competent person responsible for the Safety Data Sheet
sds@chemfix.co.uk
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H314, H317, H318, H373
Hazard statements
Code
Statements
H314
Causes severe skin burns and eye damage
Section 2
SECTION 2: Hazards identification
Adverse physicochemical, human health and environmental effects
May cause damage to organs through prolonged or repeated exposure. Causes severe skin burns and eye damage. May cause an allergic skin reaction. Causes serious eye damage.
2.2 Label elements
Labelling
Hazard pictograms
GHS05 GHS07 GHS08
Signal word
Danger
Contains
2,2,4-TRIMETHYLHEXANE-1,6-DIAMINE, QUARTZ (FINE FRACTION)
Hazard statements
H314 - Causes severe skin burns and eye damage. H317 - May cause an allergic skin reaction. H373 - May cause damage to organs (lungs) through prolonged or repeated exposure (Inhalation of dust).
Precautionary statements
P260 - Do not breathe dust/fume/gas/mist/vapours/spray. P264 - Wash hands, forearms and face thoroughly after handling. P272 - Contaminated work clothing should not be allowed out of the workplace. P280 - Wear protective clothing, eye protection, face protection. P301+P330+P331 - IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. P302+P352 - IF ON SKIN: Wash with plenty of water.
2.3 Other hazards
Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %
